Financial Statements — STVN
Balance Sheet
(in billions EUR)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 |
|---|
| Cash & Equivalents | 0.13 | 0.10 | 0.07 | 0.23 | 0.41 |
| Inventory | 0.27 | 0.25 | 0.26 | 0.21 | 0.15 |
| Total Current Assets | 0.94 | 0.88 | 0.86 | 0.85 | 0.87 |
| Goodwill | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Total Non-current Assets | 1.60 | 1.45 | 1.21 | 0.81 | 0.55 |
| Total Assets | 2.54 | 2.33 | 2.07 | 1.66 | 1.42 |
| Total Current Liabilities | 0.54 | 0.48 | 0.57 | 0.46 | 0.34 |
| Total Non-current Liabilities | 0.52 | 0.45 | 0.36 | 0.20 | 0.24 |
| Total Liabilities | 1.06 | 0.92 | 0.94 | 0.66 | 0.58 |
| Retained Earnings | 0.74 | 0.65 | 0.54 | 0.44 | 0.31 |
| Total Stockholder Equity | 1.49 | 1.40 | 1.13 | 1.00 | 0.84 |
Income Statement
(in billions EUR) (except per-share rows)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 |
|---|
| Total Revenue | 1.19 | 1.10 | 1.09 | 0.98 | 0.84 |
| Cost of Revenue* | 0.84 | 0.80 | 0.75 | 0.66 | 0.58 |
| Gross Profit | 0.34 | 0.30 | 0.34 | 0.32 | 0.27 |
| Research & Development | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 |
| Selling, General & Admin | 0.10 | 0.09 | 0.09 | 0.09 | 0.06 |
| Total Operating Expenses* | 0.15 | 0.14 | 0.14 | 0.13 | 0.10 |
| Operating Income | 0.20 | 0.16 | 0.20 | 0.19 | 0.16 |
| Interest Expense | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Pretax Income | 0.19 | 0.16 | 0.19 | 0.19 | 0.17 |
| Tax Provision | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 |
| Net Income | 0.14 | 0.12 | 0.15 | 0.14 | 0.13 |
| Basic EPS | 0.51 | 0.43 | 0.55 | 0.54 | 0.53 |
| Diluted EPS | 0.51 | 0.43 | 0.55 | 0.54 | 0.53 |
* Derived from reported values
Cash Flow Statement
(in millions EUR)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 |
|---|
| Operating Cash Flow | 286.08 | 155.78 | 105.21 | 103.31 | 133.34 |
| Investing Cash Flow | (272.92) | (310.21) | (421.22) | (242.95) | (96.43) |
| Financing Cash Flow | 22.06 | 183.22 | 158.03 | (44.54) | 254.85 |